Compass Associates
Multi-award-winning recruitment consultancy dedicated to the independent Health, Social Care and Children's Services sectors.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
University of Cambridge spin-out company STORM Therapeutics has announced that it has selected a first-in-class METTL3 candidate for development towards first in human clinical studies.